EUVIMEDEUVIMED entdecken
Crossref

Explaining the Fifth Circuit Court of Appeals Ruling on Mifepristone Access

Molly A Meegan

JAMA · 2023

DOI: 10.1001/jama.2023.21591 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA, 2023. Verfasst von Molly A Meegan. Beteiligte Einrichtung: Legal & Government Affairs Division, American College of Obstetricians and Gynecologists, Washington, DC. Hauptthemen laut MEDLINE: Abortion, Induced, Family Planning Services, Mifepristone, Health Services Accessibility. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This Viewpoint summarizes the Fifth Circuit Court of Appeals ruling on access to mifepristone, the first of 2 pills used in medication abortion.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Abortion, InducedFamily Planning ServicesMifepristoneHealth Services AccessibilityAbortifacient AgentsFemaleHumansPregnancyUnited States

Substanzen

MifepristoneAbortifacient Agents

Autor:innen und Institutionen

  • Legal & Government Affairs Division, American College of Obstetricians and Gynecologists, Washington, DC.

Zitieren

APA

Meegan, M. A. (2023). Explaining the Fifth Circuit Court of Appeals Ruling on Mifepristone Access. JAMA. https://doi.org/10.1001/jama.2023.21591

Vancouver

Meegan MA. Explaining the Fifth Circuit Court of Appeals Ruling on Mifepristone Access. JAMA. 2023. doi:10.1001/jama.2023.21591

BibTeX
@article{Meegan2023,
  author = {Meegan, Molly A},
  title = {Explaining the Fifth Circuit Court of Appeals Ruling on Mifepristone Access},
  journal = {JAMA},
  year = {2023},
  doi = {10.1001/jama.2023.21591}
}
Kostenlos starten →